Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ASCO GI 2021

ASCO Gastrointestinal Cancers Symposium Annual Meeting
ASCO GI 2021 Virtual 15-17 January

The American Society of Clinical Oncology (ASCO) Annual Gastrointestinal Cancer Symposium will be held virtually this year due to the ongoing COVID-19 pandemic and highlights the latest in the treatment and management of gastrointestinal malignancies.

Latest videos from ASCO GI 2021

View all
2:58
Upcoming updates at ASCO GI 2021: POLO, ClarIDHy & COVID-19
Rachna T. Shroff • 7 Jan 2021
3:29
Lenvatinib and pembrolizumab in microsatellite stable CRC
Richard Kim • 14 Jan 2021
2:40
Regorafenib plus pembrolizumab for first-line treatment of advanced HCC
Richard Kim • 14 Jan 2021
1:15
Key updates from ASCO GI 2021
Philippe Merle • 14 Jan 2021

Colorectal Cancer

View all
3:29
Lenvatinib and pembrolizumab in microsatellite stable CRC
Richard Kim • 14 Jan 2021
6:38
90Y-FF-21101: a P-cadherin-targeting antibody in advanced CRC
Vivek Subbiah • 11 Jan 2021
3:44
KEYNOTE-177 & CheckMate 142: checkpoint blockade in MSI-H/dMMR CRC
Heinz-Josef Lenz • 16 Jan 2021
2:39
Onvansertib for second-line treatment of KRAS-mutated mCRC
Heinz-Josef Lenz • 17 Jan 2021

Liver Cancer

View all
2:40
Regorafenib plus pembrolizumab for first-line treatment of advanced HCC
Richard Kim • 14 Jan 2021
1:15
Key updates from ASCO GI 2021
Philippe Merle • 14 Jan 2021

Bile Duct Cancer

View all
2:58
Upcoming updates at ASCO GI 2021: POLO, ClarIDHy & COVID-19
Rachna T. Shroff • 7 Jan 2021
0:59
Exciting updates from ASCO GI 2021
Vivek Subbiah • 11 Jan 2021

Gastric Cancer

View all
4:41
DESTINY-Gastric03: trastuzumab deruxtecan in HER2-overexpressing gastric cancer
Yelena Y. Janjigian • 11 Jan 2021
2:19
ASCO GI 2021: HER2-positive gastric cancer, POLO and key trials in progress
Lola A. Fashoyin-Aje • 15 Jan 2021
3:25
Molecular profiling of esophagogastric cancer patient-derived xenografts
Yelena Y. Janjigian • 11 Jan 2021
2:46
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer
Yelena Y. Janjigian • 11 Jan 2021
The content of VJOncology is intended for healthcare professionals